Genentech (Roche Group)
Subsidiary of Roche (RHHBY)
Assets
(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Approved | SMN2 pre-mRNASmall molecule | Spinal Muscular Atrophy |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.